At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Velacurother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Liver Stiffness Measurement Using Liver Incytes
In Brief
A clinical study evaluating Velacur for Portal Hypertension and Chronic Advanced Liver Disease. Completed, enrolled 70 participants across 1 site.
Detailed Summary
This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsSonic Incytes
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedOct 2020
Enrollment StartFeb 2021
Primary CompletionApr 2022
TodayJul 2026
First PostedOct 6, 2020
Enrollment StartFeb 1, 2021
Primary CompletionApr 19, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.7 years ago
Interventions
Velacurother
Ultrasound elasticity imaging